Have We Sparked Your Interest in Our Innovative Anti-oxMIF Antibody Pipeline?

We’re excited to hear from you and are open to Strategic Partnerships, Collaborations, and Investors to advance our anti-oxMIF candidates into the Clinic.

Our CEO, Randolf, looks forward to connecting with you.

Reach out to him!

Head office
in Vienna (Austria)

Cooperation partners
and a diverse team from across the globe with a united mission